Lambert Initiative for Cannabinoid Therapeutics
|Chief Investigator||University Supervisor||Closing Date|
|Sarah-Catherine Rodan||Professor Iain McGregor||30 Oct, 2024|
|Chief Investigator||Sarah-Catherine Rodan|
|University Supervisor||Professor Iain McGregor|
|Closing Date||30 Oct, 2024|
About the research trial
Researchers at the InsideOut Institute and Lambert Initiative at the University of Sydney are investigating the safety and efficacy of a new pharmacological treatment, cannabidiol, as an adjunct to Maudsley Family Based Treatment in young persons aged 12-18 with anorexia nervosa.
Cannabidiol is a non-intoxicating component of the Cannabis plant, which is often referred to as CBD. Cannabidiol has been used in clinical trials in young persons with treatment-resistant anxiety disorders showing very promising results. We want to see if it will help treatment for young persons with anorexia nervosa.
The young person may qualify if they:
If the young person decides to take part in the research, they will be asked to:
The treatment with CBD will begin at the commencement of MFBT and will continue every day for 12 weeks. In certain circumstances they may have the opportunity to continue taking CBD until the end of MFBT (week 24) as part of this trial.
Your participation to participate in research is voluntary
Reimbursement for participation:
If the young person would like to register their interest, they can complete our pre-screening questionnaire here: bit.ly/CAFTAN
You can also visit our trial website caftanstudy.com.au for additional details and resources